A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma

Kose, Mehmet; Sufliarsky, J; Beslija, S; Saip, P; Tulunay, G; Krejcy, K; Minarik, T; Fitzthum, E; Hayden, A; Melemed, A

doi:10.1016/j.ygyno.2004.10.011

A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma

Copy For Citation

Kose M. F., Sufliarsky J., Beslija S., Saip P., Tulunay G., Krejcy K., ...More

GYNECOLOGIC ONCOLOGY, vol.96, no.2, pp.374-380, 2005 (SCI-Expanded)

Publication Type: Article / Article
Volume: 96 Issue: 2
Publication Date: 2005
Doi Number: 10.1016/j.ygyno.2004.10.011
Journal Name: GYNECOLOGIC ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
Page Numbers: pp.374-380
Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

Objectives. Gemcitabine and carboplatin each have demonstrated effectiveness without increased neurotoxicity in pretreated patients with ovarian cancer. We evaluated the efficacy and safety of gemcitabine plus carboplatin in patients with recurrent ovarian cancer in a multicenter phase II study.